Equities

GoodRx Holdings Inc

GDRX:NSQ

GoodRx Holdings Inc

Actions
  • Price (USD)7.23
  • Today's Change-0.009 / -0.12%
  • Shares traded508.47k
  • 1 Year change+40.68%
  • Beta1.3755
Data delayed at least 15 minutes, as of May 24 2024 19:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.

  • Revenue in USD (TTM)764.16m
  • Net income in USD-6.59m
  • Incorporated2015
  • Employees694.00
  • Location
    GoodRx Holdings Inc2701 Olympic Boulevard, Suite 990SANTA MONICA 90404United StatesUSA
  • Fax+1 (302) 636-5454
  • Websitehttps://investors.goodrx.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AMN Healthcare Services, Inc.3.48bn143.90m2.15bn3.59k15.252.526.940.61823.723.7290.4822.521.21--4.25971,801.705.009.326.6512.4132.6732.964.136.62--4.180.59790.00-27.7312.15-52.568.2523.70--
Mister Car Wash Inc940.29m75.63m2.18bn6.60k29.602.3314.712.310.230.232.862.920.3333--253.86142,468.602.68--2.85------8.046.170.25812.410.50170.005.7712.07-29.0341.06----
Yelp Inc1.36bn114.51m2.46bn4.87k23.393.4515.761.811.561.5618.5510.571.35--9.42278,607.6011.363.6514.104.2491.4992.348.443.61----0.000.0012.037.24172.8512.37-9.80--
CarGurus Inc898.08m36.27m2.46bn1.34k73.654.3647.812.740.32060.32068.015.410.9343223.5116.76668,708.103.289.893.8212.5074.7664.963.517.102.78--0.000.00-44.7615.02-83.95-13.7540.68--
Ziff Davis Inc1.37bn59.76m2.51bn4.20k42.141.328.631.831.291.2929.6841.230.3781--3.78326,516.901.673.261.973.9485.5285.164.428.94--5.500.3457.61-1.942.47-36.58-20.0213.77--
ICF International Inc1.97bn93.53m2.67bn9.00k28.962.9217.521.354.934.93104.0048.850.9654--4.69219,376.904.573.975.595.0936.0335.954.744.13--4.000.348715.4210.307.9728.596.110.47680.00
Frontdoor Inc1.79bn183.00m2.71bn1.72k15.3716.8412.261.512.272.2722.312.071.58--358.201,043,706.0016.2710.8524.3715.8350.7547.8610.338.08--12.260.78460.007.107.19140.856.473.46--
Goodrx Holdings Inc764.16m-6.59m2.72bn694.00--4.3026.613.55-0.018-0.0181.891.680.4986--5.851,101,094.00-0.4298-4.89-0.4574-5.1791.8093.05-0.862-9.20--0.83770.5088---2.1224.6372.99--74.38--
Global Business Travel Group Inc2.32bn-80.00m2.75bn19.00k--2.3440.981.18-0.3694-0.36946.622.480.5966--2.67122,210.50-3.29---5.42--58.57---5.51----0.71430.5373--23.72---152.00------
ABM Industries Inc8.17bn257.50m2.99bn123.00k12.061.647.980.36563.923.92124.6628.801.66--5.6266,460.985.223.506.934.7412.9714.163.152.13--5.160.421634.993.714.689.0728.805.014.23
UniFirst Corp2.33bn114.69m3.04bn16.00k26.681.4912.271.306.116.11124.31109.740.91939.948.21145,799.604.525.985.016.6434.1035.574.926.962.69--0.0013.1511.615.650.2611-6.338.8140.46
Instructure Holdings Inc556.82m-43.35m3.15bn1.50k--2.4728.115.66-0.2994-0.29943.858.760.2293--9.62372,207.20-1.78---2.01--65.9361.62-7.78-22.22--0.58360.4733--11.5820.400.4789---11.81--
Sotera Health Co1.08bn54.57m3.17bn3.00k58.117.3813.812.940.19260.19263.811.520.33279.878.36358,958.001.69-0.8681.92-0.966455.0554.405.09-2.682.862.350.8439--4.547.06121.87--24.24--
Korn Ferry2.83bn148.43m3.43bn10.70k22.772.0214.851.212.892.8955.1432.550.814--4.65264,906.604.456.005.908.0487.8793.495.477.73----0.188615.288.349.50-35.777.1810.888.45
Data as of May 24 2024. Currency figures normalised to GoodRx Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

39.22%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 20248.01m8.59%
Columbia Management Investment Advisers LLCas of 31 Mar 20247.44m7.98%
Millennium Management LLCas of 25 Apr 20244.83m5.18%
Lakewood Capital Management LPas of 31 Mar 20243.31m3.54%
Renaissance Technologies LLCas of 31 Mar 20243.08m3.30%
Petrus Securities LPas of 31 Mar 20242.30m2.47%
Rubric Capital Management LPas of 31 Mar 20242.12m2.27%
Rip Road Capital Partners LPas of 31 Mar 20242.06m2.21%
Dimensional Fund Advisors LPas of 31 Mar 20241.93m2.07%
BlackRock Fund Advisorsas of 31 Mar 20241.51m1.62%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.